|
시장보고서
상품코드
2053896
단일 분자 실시간 시퀀싱 시장 규모, 점유율, 성장 분석 : 제공 서비스별, 워크플로우별, 용도별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)Single-molecule Real-time Sequencing Market Size, Share, and Growth Analysis, By Offering, By Workflow, By Application, By End User, By Region - Industry Forecast 2026-2033 |
||||||
세계의 단일 분자 실시간(SMRT) 시퀀싱 시장 규모는 2024년에 32억 달러로 평가되었으며, 2025년 35억 7,000만 달러에서 2033년까지 86억 6,000만 달러로 확대되어 예측 기간(2026-2033년) 동안 CAGR 11.7%로 성장할 것으로 전망됩니다.
세계 단일 분자 실시간(SMRT) 시퀀싱 시장은 주로 짧은 리드 플랫폼으로는 조립할 수 없는 복잡한 유전체 영역을 분석할 수 있는 긴 고충실도 리드(long, high-fidelity reads)라는 독보적인 능력에 의해 주도되고 있습니다. SMRT 기술은 정확한 구조적 돌연변이 검출, 페이싱 및 염기 변형의 직접적인 식별을 가능하게 하여 정밀 의학, 농업유전체학, 미생물 생태학에 응용하는 데 필수적인 기술입니다. 고충실도 리드를 통한 정확도와 처리량 향상으로 이 기술의 유용성이 확대되어 종합적인 유전체 어셈블리 및 임상 진단에 일상적으로 활용될 수 있게 되었습니다. 비용 절감과 샘플 조제의 간소화로 인해, 그 채택은 틈새 프로젝트의 틀을 넘어서고 있습니다. 인공지능(AI)은 정확도와 처리량을 더욱 향상시키고, 워크플로우를 최적화하고, 오류를 줄임으로써 SMRT 시퀀싱 분야의 성장을 촉진하고 새로운 수익원을 창출하고 있습니다.
세계 단일 분자 실시간(SMRT) 시퀀싱 시장의 성장요인
세계 단일 분자 실시간(SMRT) 시퀀싱 시장의 주요 시장 촉진요인 중 하나는 맞춤형 의료 및 유전체 연구에 대한 수요 증가입니다. 헬스케어가 개인 유전자 정보에 기반한 맞춤형 치료로 전환함에 따라 첨단 시퀀싱 기술에 대한 수요가 급증하고 있습니다. SMRT 시퀀싱은 롱리드 기능과 복잡한 유전체 영역의 분석에서 높은 정확도를 제공하여 연구자와 임상의가 중요한 유전적 변이와 돌연변이를 규명할 수 있게 해줍니다. 이 기능은 다양한 질병에 대한 이해를 높이고 표적 치료법 개발을 가속화하여 유전체학 및 생명공학에 초점을 맞춘 학계와 산업 분야 모두에서 성장을 촉진할 수 있습니다.
세계 단일 분자 실시간(SMRT) 시퀀싱 시장의 억제요인
세계 단일 분자 실시간(SMRT) 시퀀싱 시장의 주요 시장 억제요인 중 하나는 첨단 시퀀싱 기술에 따른 높은 비용입니다. SMRT 시퀀싱 장비의 도입 및 유지보수에는 많은 자금 투자가 필요하며, 이는 예산이 한정된 소규모 연구기관 및 연구소의 진입장벽이 될 수 있습니다. 또한, 이 기술의 복잡성으로 인해 전문적인 교육과 전문 지식이 필요하며, 운영 비용이 더욱 증가합니다. 이러한 요인들은 학계, 헬스케어 및 생명공학 분야의 잠재적 사용자들의 광범위한 도입을 방해할 수 있으며, 결과적으로 기술의 발전과 잠재적 응용 분야에도 불구하고 전체 시장의 성장을 제한할 수 있습니다.
세계 단일 분자 실시간(SMRT) 시퀀싱 시장 동향
전 세계 단일 분자 실시간(SMRT) 시퀀싱 시장에서는 기존의 유전체 연구를 넘어 번역 연구 및 임상 연구와 같은 보다 복잡한 분야로 확장되는 임상 연구 용도의 두드러진 추세를 볼 수 있습니다. 이러한 변화는 SMRT 시퀀싱이 긴 리드, 후생유전학적 변형 및 복잡한 구조적 변이를 정확하게 분석할 수 있는 능력에 힘입어 더욱 가속화되고 있습니다. 그 결과, 의료 기관에서는 바이오마커 발견, 희귀 질환 진단 및 약물유전체학의 발전으로 인해 이러한 기술을 점점 더 많이 활용하고 있습니다. 임상 실험실과 연구기관 간의 협력에 대한 수요가 증가함에 따라 검증된 방법과 표준화된 프로토콜의 필요성이 대두되고 있으며, 임상 도입과 실행을 용이하게 하기 위한 턴키 플랫폼과 종합적인 지원 서비스에 대한 시장의 요구가 더욱 부각되고 있습니다.
자주 묻는 질문
목차
소개
조사 방법
주요 요약
시장 역학과 전망
주요 시장 인사이트
세계의 단일 분자 실시간 시퀀싱 시장 규모 : 제공 서비스별
세계의 단일 분자 실시간 시퀀싱 시장 규모 : 워크플로우별
세계의 단일 분자 실시간 시퀀싱 시장 규모 : 용도별
세계의 단일 분자 실시간 시퀀싱 시장 규모 : 최종사용자별
세계의 단일 분자 실시간 시퀀싱 시장 규모 : 지역별
경쟁 정보
주요 기업 개요
결론과 제안
KSM 26.06.12Global Single-Molecule Real-Time (Smrt) Sequencing Market size was valued at USD 3.2 Billion in 2024 and is poised to grow from USD 3.57 Billion in 2025 to USD 8.66 Billion by 2033, growing at a CAGR of 11.7% during the forecast period (2026-2033).
The global Single-Molecule Real-Time (SMRT) sequencing market is primarily driven by the unparalleled capability of long, high-fidelity reads to uncover complex genomic regions that short-read platforms fail to assemble. SMRT technology facilitates accurate structural variant detection, phasing, and direct identification of base modifications, making it essential for applications in precision medicine, agricultural genomics, and microbial ecology. The advances in accuracy and throughput due to high-fidelity reads have expanded the technology's utility, enabling comprehensive genome assemblies and routine use in clinical diagnostics. With decreasing costs and simplified sample preparation, adoption has moved beyond niche projects. Artificial intelligence further enhances accuracy and processing throughput, optimizing workflows and reducing errors, catalyzing growth and fostering new revenue streams in the SMRT sequencing landscape.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Single-Molecule Real-Time (Smrt) Sequencing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Single-Molecule Real-Time (Smrt) Sequencing Market Segments Analysis
Global single-molecule real-time (smrt) sequencing market is segmented by offering, workflow, application, end user and region. Based on offering, the market is segmented into Instruments, Consumables & Reagents, Software & Bioinformatics Solutions and Sequencing Services. Based on workflow, the market is segmented into Sample Preparation & Library Preparation, Sequencing and Data Processing & Analysis. Based on application, the market is segmented into Whole Genome Sequencing, Targeted Sequencing, RNA Sequencing & Transcriptomics, Epigenetics & Methylation Analysis, Metagenomics & Microbial Sequencing, Structural Variant Detection, De Novo Genome Assembly, HLA Typing & Immunogenomics, Rare Disease & Genetic Disorder Research, Oncology Research & Cancer Genomics, Agricultural & Animal Genomics, Drug Discovery & Development and Others. Based on end user, the market is segmented into Academic & Research Institutes, Pharmaceutical & Biotechnology Companies, Hospitals & Clinical Laboratories, Contract Research Organizations (CROs), Government & Public Health Laboratories and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Single-Molecule Real-Time (Smrt) Sequencing Market
One key market driver for the Global Single-Molecule Real-Time (SMRT) Sequencing Market is the increasing demand for personalized medicine and genomic research. As healthcare shifts towards more tailored treatments based on individual genetic information, the need for advanced sequencing technologies has surged. SMRT sequencing allows for long-read capabilities and higher accuracy in characterizing complex genomic regions, enabling researchers and clinicians to uncover critical genetic variations and mutations. This capability enhances the understanding of various diseases and accelerates the development of targeted therapies, thereby fostering growth in both academic and industrial sectors focused on genomics and biotechnology.
Restraints in the Global Single-Molecule Real-Time (Smrt) Sequencing Market
One of the primary market restraints for the Global Single-Molecule Real-Time (SMRT) Sequencing Market is the high cost associated with advanced sequencing technologies. The installation and maintenance of SMRT sequencing instruments require significant financial investment, which can be a barrier to entry for smaller research institutions and laboratories with limited budgets. Additionally, the complexity of the technology necessitates specialized training and expertise, further increasing operational costs. These factors may hinder widespread adoption among potential users in academia, healthcare, and biotechnology sectors, thereby limiting the overall growth of the market despite its technological advancements and potential applications.
Market Trends of the Global Single-Molecule Real-Time (Smrt) Sequencing Market
The Global Single-Molecule Real-Time (Smrt) Sequencing market is experiencing a significant trend towards expanded clinical research applications, moving beyond traditional genomic studies into more complex areas such as translational and clinical research. This shift is fueled by Smrt sequencing's capability to accurately resolve long reads, epigenetic modifications, and intricate structural variants. Consequently, healthcare institutions are increasingly utilizing these technologies for biomarker discovery, diagnosing rare diseases, and advancing pharmacogenomics. The burgeoning demand for collaboration between clinical laboratories and research institutions is driving the need for validated methods and standardized protocols, further highlighting the market's requirement for turnkey platforms and comprehensive support services to facilitate clinical adoption and implementation.
Table of Contents
Introduction
- Objectives of the Study
- Market Definition & Scope
Research Methodology
- Research Process
- Secondary & Primary Data Methods
- Market Size Estimation Methods
Executive Summary
- Global Market Outlook
- Key Market Highlights
- Segmental Overview
- Competition Overview
Market Dynamics & Outlook
- Macro-Economic Indicators
- Drivers & Opportunities
- Restraints & Challenges
- Supply Side Trends
- Demand Side Trends
- Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Key Market Insights
- Key Success Factors
- Market Impacting Factors
- Top Investment Pockets
- Ecosystem Mapping
- Market Attractiveness Index 2025
- PESTEL Analysis
- Regulatory Landscape
Global Single-molecule Real-time (SMRT) Sequencing Market Size by Offering & CAGR (2026-2033)
- Market Overview
- Instruments
- Consumables & Reagents
- Software & Bioinformatics Solutions
- Sequencing Services
Global Single-molecule Real-time (SMRT) Sequencing Market Size by Workflow & CAGR (2026-2033)
- Market Overview
- Sample Preparation & Library Preparation
- Sequencing
- Data Processing & Analysis
Global Single-molecule Real-time (SMRT) Sequencing Market Size by Application & CAGR (2026-2033)
- Market Overview
- Whole Genome Sequencing
- Targeted Sequencing
- RNA Sequencing & Transcriptomics
- Epigenetics & Methylation Analysis
- Metagenomics & Microbial Sequencing
- Structural Variant Detection
- De Novo Genome Assembly
- HLA Typing & Immunogenomics
- Rare Disease & Genetic Disorder Research
- Oncology Research & Cancer Genomics
- Agricultural & Animal Genomics
- Drug Discovery & Development
- Others
Global Single-molecule Real-time (SMRT) Sequencing Market Size by End User & CAGR (2026-2033)
- Market Overview
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinical Laboratories
- Contract Research Organizations (CROs)
- Government & Public Health Laboratories
- Others
Global Single-molecule Real-time (SMRT) Sequencing Market Size & CAGR (2026-2033)
- North America (Offering, Workflow, Application, End User)
- US
- Canada
- Europe (Offering, Workflow, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Offering, Workflow, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Offering, Workflow, Application, End User)
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa (Offering, Workflow, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- Pacific Biosciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Illumina
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oxford Nanopore Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BGI Genomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- QIAGEN
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Roche
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agilent Technologies
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Revvity
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Standard BioTools
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Takara Bio
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Azenta Life Sciences
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GeneDx
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Novogene
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Macrogen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GenScript Biotech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Psomagen
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- CD Genomics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- SeqMatic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Genewiz
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
